Lidocaine-d6 (hydrochloride) is a deuterated analog of Lidocaine (hydrochloride), used as a research tool to study voltage- and time-dependent sodium channel inhibition; it reduces gastric cancer cell proliferation, migration, and invasion by modulating miR-145 expression and subsequently inhibiting the MEK/ERK and NF-κB signaling pathways; it serves as an amide-type local anesthetic and antiarrhythmic agent for investigating ventricular arrhythmias, and exhibits potent antitumor activity.